Diseases, Conditions, Syndromes

BioNTech says 'no evidence' its jabs need adapting for variants

German firm BioNTech said Monday that the COVID-19 vaccine it developed with Pfizer does not require any modifications to work against variants of the virus, as it announced new plans to ramp up production of the jabs.

Vaccination

EXPLAINER: How activists target CDC vaccine tracking system

Once, getting vaccinated was all but routine. But since the heightened public awareness around the new COVID-19 vaccines, it's a different story. Now, it means check-ins with family and friends about possible arm soreness ...

page 22 from 40